跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIPERACILLIN AND TAZOBACTAM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Authorized
STANDARD
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fb35b50585d6b2e9
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
fb35b50585d6b2e9
Drug Approval Canada Name
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Product Name
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Status
Cancelled Post Market
Status Date
2025-06-10
Original Market Date
2022-01-06
Din
02465833
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.16.16
Atc Original
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 05
Aig Number
0225919008
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
PIPERACILLIN (PIPERACILLIN SODIUM)
36 G / VIAL
TAZOBACTAM (TAZOBACTAM SODIUM)
4.5 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fb35b50585d6b2e9
Type
Standard
Back to Health Canada Approvals